As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

That’s a bit harsh given Denmark’s strong growth compared with neighboring countries over the past few years has been largely ...

HSBC has once again reduced its price target for Eli Lilly, this time dropping it to $675 from $700 while maintaining a ...